20/07/2026

Barcelona, July 2026– Anapharm Bioanalytics is pleased to announce the successful renewal of its Good Laboratory Practice (GLP) certification following the latest inspection conducted by local authority, Generalitat de Catalunya, in June 2026.
Anapharm has operated under GLP compliance since 2003 and the renewed certificate is valid until June 2028. The recent on-site inspection concluded with no observations and no findings, an outstanding result that reflects the robustness of the company’s quality system.

READ MORE

30/06/2026

In this blog post, we will take a closer look at the importance of CSV in a GLP & GCP environment and explore some of the key computerized systems that play a critical role in supporting our laboratory operations and ensuring data quality.

READ MORE

18/03/2026

In this 30-minute on-demand webinar, discover practical strategies to troubleshoot common analytical challenges, from small molecules to complex peptides, illustrated with real case studies from our laboratory.

READ MORE

27/02/2026

Detecting anti-PEG antibodies in clinical immunogenicity testing of PEGylated therapeutics presents unique bioanalytical challenges: from PEG’s repetitive structure causing low signal-to-noise ratios in standard assay formats, to selecting appropriate positive controls and distinguishing anti-drug from anti-PEG antibodies. This blog describes how the bioanalytical team at Anapharm Bioanalytics addressed these challenges during the development and validation of an immunogenicity assay using the Affinity Capture Elution–AGL (ACE-AGL) MSD immunoassay format.

READ MORE

18/12/2025

Quantitative bioanalysis of therapeutic proteins via liquid chromatography–mass spectrometry (LC-MS) typically relies on the analysis of surrogate peptides rather than intact proteins. Selecting the right digestion method impacts sensitivity, reproducibility, and cost. This blog compares three approaches tested in-house at Anapharm: standard trypsin digestion, the use of a kit with a thermostable immobilized trypsin, and a kit with ready-to-use reagents.

READ MORE

04/12/2025

Tissue sample homogenization strategies for LC-MS/MS bioanalysis for skin, brain, and challenging matrices. Solve homogenization and matrix effect challenges.

READ MORE

06/11/2025

The poster we presented at the 11th EBF Young Scientist Symposium highlights the main challenges encountered during the development and validation of an analytical method for the determination of a peptibody by electrochemiluminescence immunoassay (ECLIA, required sensitivity 15 – 20 pg/mL), and describes the approaches implemented to overcome them.

READ MORE

29/10/2025

Learn how ion-pairing agents, like perfluorinated acids, solve basic peptide LC-MS/MS analysis challenges: poor retention, carryover, & low recovery.

READ MORE

02/10/2025

Aptamers are single-stranded DNA or RNA sequences with high stability and affinity for their binding targets. They are less immunogenic and toxic than other therapeutic molecules and easier to be internalised by cells, making them suitable for drug delivery. Anapharm has developed two bioanalytical methods to detect and quantify the Chimera and its components (Aptamer and RNAi) of an RNAi-linked Aptamer sequence in murine matrices.

READ MORE